Technical Analysis for RSLS - Reshape Lifesciences Inc

Grade Last Price % Change Price Change
grade A 0.348 2.35% 0.0080
RSLS closed up 2.35 percent on Monday, March 18, 2019, on 32 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical RSLS trend table...

Date Alert Name Type % Chg
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.35%
Mar 13 Doji - Bullish? Reversal 5.45%
Mar 13 Lower Bollinger Band Walk Weakness 5.45%
Mar 13 Outside Day Range Expansion 5.45%
Mar 13 Lower Bollinger Band Touch Weakness 5.45%
Mar 12 Narrow Range Bar Range Contraction 5.45%
Mar 12 Inside Day Range Contraction 5.45%
Mar 11 20 DMA Resistance Bearish 7.74%
Mar 11 Inside Day Range Contraction 7.74%

Older signals for RSLS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.
Medicine Medical Specialties Clinical Medicine Obesity Metabolic Diseases Digestive System Surgery Gastrointestinal Disorders Vagus Nerve Laparoscopy
Is RSLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.4
52 Week Low 0.21
Average Volume 99,298
200-Day Moving Average 0.0
50-Day Moving Average 0.3253
20-Day Moving Average 0.3513
10-Day Moving Average 0.3447
Average True Range 0.0344
ADX 16.73
+DI 9.9543
-DI 19.1189
Chandelier Exit (Long, 3 ATRs ) 0.2858
Chandelier Exit (Short, 3 ATRs ) 0.4032
Upper Bollinger Band 0.3794
Lower Bollinger Band 0.3232
Percent B (%b) 0.44
BandWidth 15.997723
MACD Line 0.0025
MACD Signal Line 0.0063
MACD Histogram -0.0039
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3780
Resistance 3 (R3) 0.3753 0.3627 0.3730
Resistance 2 (R2) 0.3627 0.3550 0.3640 0.3713
Resistance 1 (R1) 0.3553 0.3503 0.3590 0.3580 0.3697
Pivot Point 0.3427 0.3427 0.3445 0.3440 0.3427
Support 1 (S1) 0.3353 0.3350 0.3390 0.3380 0.3263
Support 2 (S2) 0.3227 0.3303 0.3240 0.3247
Support 3 (S3) 0.3153 0.3227 0.3230
Support 4 (S4) 0.3180